Mr Adonys Acosta Rodriguez, MD in South Miami, FL - Student in an Organized Health Care Education/Training Program

Mr Adonys Acosta Rodriguez, MD is a Student In An Organized Health Care Education/training Program physician based in South Miami, Florida. Mr Adonys Acosta Rodriguez is licensed to practice in * (Not Available) (license number ) and his current practice location is 7031 Sw 62nd Ave, South Miami, Florida. He can be reached at his office (for appointments etc.) via phone at (305) 284-7761.

NPI number for Mr Adonys Acosta Rodriguez is 1356970594 and his current mailing address is 7031 Sw 62nd Ave, South Miami, Florida. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1356970594.

Contact Information

	Mr Adonys Acosta Rodriguez, MD
	7031 Sw 62nd Ave, South Miami, FL 33143-4701
	(305) 284-7761
	Not Available

Physician's Profile

Full Name	Mr Adonys Acosta Rodriguez
Gender	Male
Speciality	Student In An Organized Health Care Education/training Program
Location	7031 Sw 62nd Ave, South Miami, Florida
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1356970594
Provider Enumeration Date: 04/08/2020
Last Update Date: 04/08/2024

Medical Identifiers

Medical identifiers for Mr Adonys Acosta Rodriguez such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1356970594	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
208D00000X	General Practice	16763-I (Puerto Rico)	Secondary
363LF0000X	Nurse Practitioner - Family	11006535 (Florida)	Secondary
390200000X	Student In An Organized Health Care Education/training Program	(* (Not Available))	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Mr Adonys Acosta Rodriguez is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Mr Adonys Acosta Rodriguez, MD 7031 Sw 62nd Ave, South Miami, FL 33143-4701 Ph: (305) 284-7761	Mr Adonys Acosta Rodriguez, MD 7031 Sw 62nd Ave, South Miami, FL 33143-4701 Ph: (305) 284-7761

News Archive

Mass. legislators seek to resolve House, Senate difference on bill to curb health costs

Six lawmakers were selected Thursday to negotiate the differences between House and Senate proposals for controlling health care spending in the state. The conference committee will include Senator Richard Moore and Representative Steven Walsh, both Democrats, who led efforts to craft the two bills.

In New Jersey, cosmetic surgery tax raised funds far below projections

Bloomberg: "A tax on breast enhancements and other cosmetic care, similar to one proposed in the U.S. Senate's health-overhaul legislation, doesn't generate even a third of the $30 million a year originally projected for it in New Jersey, the only state with such a levy."

China Aoxing submits an NDA to the China SFDA for its Codeine Phosphate

China Aoxing Pharmaceutical Company, Inc. (OTCBB: CAXG) ("China Aoxing"), a pharmaceutical company specializing in research, development, manufacturing and marketing of narcotic and pain-management products, today announced that it has submitted a new drug application (NDA) to the China State Food and Drug Administration (SFDA) for its Codeine Phosphate, a compound oral solution for the treatment of acute moderate to severe cough.

Gentium reports results from phase 3 trial of defibrotide for severe veno-occlusive disease

Gentium S.p.A. has announced top-line results from a historically controlled, multicenter, open label, Phase III trial designed to evaluate the safety and efficacy of 25 mg/kg/day of Defibrotide for the treatment of severe veno-occlusive disease (sVOD) in hematopoietic stem cell transplant (SCT) patients.

Abbott Prism HIV O Plus assay approved by FDA

The U. S. Food and Drug Administration today announced approval of the Abbott Prism HIV O Plus assay, as a screening tool designed to detect the presence of certain antibodies to HIV. The assay is one of five assays that run on the fully automated Abbott Prism System.

Mr Adonys Acosta Rodriguez, MD - Student in an Organized Health Care Education/Training Program in South Miami, FL